Suppr超能文献

农村河滨地区初级卫生保健团队服务人群接受巴氏涂片宫颈癌筛查的障碍。

Barriers to Access the Pap Smear Test for Cervical Cancer Screening in Rural Riverside Populations Covered by a Fluvial Primary Healthcare Team in the Amazon.

机构信息

Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz, Rua Teresina 476, Manaus 69057-070, Brazil.

Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Av. Carvalho Leal 1777, Manaus 69065-001, Brazil.

出版信息

Int J Environ Res Public Health. 2022 Apr 1;19(7):4193. doi: 10.3390/ijerph19074193.

Abstract

Cervical cancer is a major public health problem, especially in the north region of Brazil. The aim of the study was to identify the factors associated with not undergoing the cervical cancer screening test in rural riverside populations in the Amazon. A cross-sectional home-based survey was carried out in 38 locations covered by a fluvial primary healthcare team, and the administrative records of the screening tests from January 2016 to May 2019 were analyzed. After the descriptive analysis, logistic regression was performed considering the outcome of having undergone cervical cancer screening within the past three years. Of the 221 women assessed, 8.1% had never undergone the test, and 7.7% had undergone it more than three years ago. Multiparity (OR = 0.76 (95%CI = 0.64-0.90)), occupation in domestic activities (OR = 0.31 (95%CI = 0.11-0.89)), and lack of knowledge of the healthcare unit responsible for the service (OR = 0.18 (95%CI = 0.04-0.97)) were associated with not undergoing the cervical cancer screening test. The administrative records revealed that the screening test was performed outside the recommended age range (24%), performed needlessly (9.6%) with undue repetitions (3.2%), and a high percentage of the samples collected were unsatisfactory (23.5%). The findings revealed the existence of barriers for riverside women to access cervical cancer screening tests.

摘要

宫颈癌是一个主要的公共卫生问题,尤其是在巴西北部地区。本研究旨在确定与亚马孙地区农村河边人口未接受宫颈癌筛查相关的因素。在由河流水域初级保健团队覆盖的 38 个地点进行了一项基于家庭的横断面调查,并对 2016 年 1 月至 2019 年 5 月期间的筛查测试的行政记录进行了分析。在描述性分析之后,对在过去三年内接受过宫颈癌筛查的结果进行了逻辑回归分析。在所评估的 221 名女性中,8.1%的人从未接受过该检查,7.7%的人在三年前接受过该检查。多胎产(OR = 0.76(95%CI = 0.64-0.90))、从事家务活动的职业(OR = 0.31(95%CI = 0.11-0.89))和缺乏对负责服务的医疗机构的了解(OR = 0.18(95%CI = 0.04-0.97))与未接受宫颈癌筛查测试有关。行政记录显示,筛查测试在推荐年龄范围之外进行(24%),不必要地进行(9.6%)且重复次数过多(3.2%),并且采集的样本中不满意的比例很高(23.5%)。研究结果表明,河边妇女在获得宫颈癌筛查测试方面存在障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861d/8998957/93fd82a3f95d/ijerph-19-04193-g001.jpg

相似文献

4
A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Int J Epidemiol. 1999 Feb;28(1):35-9. doi: 10.1093/ije/28.1.35.
7
Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3379-3387. doi: 10.22034/APJCP.2017.18.12.3379.
8
Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
BMC Womens Health. 2023 Jul 25;23(1):389. doi: 10.1186/s12905-023-02553-3.

本文引用的文献

2
Human papillomavirus (HPV) vaccination coverage in Brazil: spatial and age cohort heterogeneity.
Rev Bras Epidemiol. 2020 Dec 18;24:e210001. doi: 10.1590/1980-549720210001. eCollection 2020.
3
4
Cervical cancer: knowledge, attitude and practice on the prevention examination.
Rev Bras Enferm. 2019 Dec;72(suppl 3):25-31. doi: 10.1590/0034-7167-2017-0645.
5
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
6
[Access to uterine cervical cytology in a health region: invisible women and vulnerable bodies].
Cad Saude Publica. 2019 Oct 7;35(10):e00234618. doi: 10.1590/0102-311X00234618. eCollection 2019.
7
Cervical cancer control limiting factors and facilitators: a literature review.
Cien Saude Colet. 2019 Sep 9;24(9):3431-3442. doi: 10.1590/1413-81232018249.32592017.
9
Evaluation of non-attendance for Pap test through the Surveillance System by telephone survey.
Rev Esc Enferm USP. 2018 Nov 23;52(0):e03390. doi: 10.1590/S1980-220X2017029503390.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验